Clinical Takeaway In this phase 3 trial of 820 adults with chronic low back pain, the full-spectrum cannabis extract VER-01 was evaluated over a 12-week double-blind period followed by longer-term open-label phases....
`Endocannabinoid System Trial: Cannabis for Chronic Back Pain`
Clinical Takeaway In this phase 3 randomized controlled trial, 820 adults with chronic low back pain received either VER-01, a full-spectrum cannabis extract, or placebo over a 12-week double-blind period, followed by...
endocannabinoid system clinical research: Phase 3 Cannabis Trial
Clinical Takeaway In this phase 3 randomized controlled trial of 820 adults with chronic low back pain, VER-01, a full-spectrum cannabis extract, was evaluated over a 12-week blinded treatment period with extended...
`Cannabinoid Clinical Trials: Full-Spectrum Cannabis for Back Pain`
Clinical Takeaway In this phase 3 randomized controlled trial of 820 adults with chronic low back pain, the full-spectrum cannabis extract VER-01 was evaluated over a 12-week double-blind period with up to...
`Endocannabinoid System & Cannabis for Chronic Back Pain Trial`
Clinical Takeaway In this phase 3 trial of 820 adults with chronic low back pain, the full-spectrum cannabis extract VER-01 was evaluated against placebo over 12 weeks with extended follow-up periods reaching...
`Endocannabinoid System & Cannabis for Chronic Back Pain Trial`
Clinical Takeaway In this phase 3 trial of 820 adults with chronic low back pain, the full-spectrum cannabis extract VER-01 was evaluated against placebo over 12 weeks with extended follow-up reaching 15...
medical cannabis evidence-based care: Phase 3 Trial Results
Clinical Takeaway In this phase 3 trial of 820 adults with chronic low back pain, the full-spectrum cannabis extract VER-01 was evaluated over a 12-week double-blind treatment period with extensions up to...